Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Nov 10, 2023 4:23pm
91 Views
Post# 35729366

RE:RE:RE:RE:Investissement Quebec(IQ)

RE:RE:RE:RE:Investissement Quebec(IQ)WE dont know but IQ knows and so does Soleus...What we know is that THTX has very wide discretion in the use of funds as per the Financing Documents...
What is preposterous is to think that IQ  .s mission is to save management s behind.....



Mannequin wrote:

Obviously we would be gone if we did not subscribe to that. However, what has changed in the past 3 weeks from what you saw in the past 3 years?  Is there more transparency? Do you know why funds were raised? Do you know why that much was raised?  And, why did we need that much? Is there any information on more than 1 trial site operational?  Are we continung along with any earlier ph1a or 1b patients?  

We know nothing, just like before.  And what you have seen is that the past tells us that even if we are told something, it's not true either. 

palinc2000 wrote: Its not about forgetting the past and I surely will not forget....But I dont intend to live in the past 

Mannequin wrote: My issue and others here is this. Those who forget the past are doomed to releat it.

palinc2000 wrote:

Investing is about the future NOT the past!
IQ 's decision came after a 6 month minimum DD..
Did they get in on the cheap? They may have requested THTX to do a Share Consolidation as a pre requisite .Of course legacy shareholders were thrown under the bus with a 50 % dilution at rock bottom pricing...But that is water under the Bridge!
You all can keep lamenting or try to see if there is hope for a substantial share price appreciation in the future.... IQ surely thinks so! They have the benifit of having seen the Business Plan ....Marathon will be dealt with .... somehow
Life is too short to keep looking at the rear view mirror

 






 



<< Previous
Bullboard Posts
Next >>